293 related articles for article (PubMed ID: 38334329)
1. Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
Vanslambrouck JM; Neil JA; Rudraraju R; Mah S; Tan KS; Groenewegen E; Forbes TA; Karavendzas K; Elliott DA; Porrello ER; Subbarao K; Little MH
J Virol; 2024 Mar; 98(3):e0180223. PubMed ID: 38334329
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
3. P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation.
Liu M; Lu B; Li Y; Yuan S; Zhuang Z; Li G; Wang D; Ma L; Zhu J; Zhao J; Chan CC; Poon VK; Chik KK; Zhao Z; Xian H; Zhao J; Zhao J; Chan JF; Zhang Y
Signal Transduct Target Ther; 2023 Oct; 8(1):385. PubMed ID: 37806990
[TBL] [Abstract][Full Text] [Related]
4. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
[TBL] [Abstract][Full Text] [Related]
5. Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2.
Guo X; Cao J; Cai JP; Wu J; Huang J; Asthana P; Wong SKK; Ye ZW; Gurung S; Zhang Y; Wang S; Wang Z; Ge X; Kwan HY; Lyu A; Chan KM; Wong N; Huang J; Zhou Z; Bian ZX; Yuan S; Wong HLX
Nat Commun; 2022 Dec; 13(1):7907. PubMed ID: 36564389
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS.
Zorad S; Skrabanova M; Zilkova M; Cente M; Turic Csokova N; Kovacech B; Cizkova D; Filipcik P
Physiol Res; 2024 Mar; 73(1):27-35. PubMed ID: 38466002
[TBL] [Abstract][Full Text] [Related]
7. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
Han Y; Duan X; Yang L; Nilsson-Payant BE; Wang P; Duan F; Tang X; Yaron TM; Zhang T; Uhl S; Bram Y; Richardson C; Zhu J; Zhao Z; Redmond D; Houghton S; Nguyen DT; Xu D; Wang X; Jessurun J; Borczuk A; Huang Y; Johnson JL; Liu Y; Xiang J; Wang H; Cantley LC; tenOever BR; Ho DD; Pan FC; Evans T; Chen HJ; Schwartz RE; Chen S
Nature; 2021 Jan; 589(7841):270-275. PubMed ID: 33116299
[TBL] [Abstract][Full Text] [Related]
8. Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS-CoV-2 Pseudovirus Entry into Lung ACE2
Yang H; Zhou JN; Zhang XM; Ling DD; Sun YB; Li CY; Zhou QQ; Shi GN; Wang SH; Lin XS; Fan T; Wang HY; Zeng Q; Jia YL; Xi JF; Jin YG; Pei XT; Yue W
Adv Mater; 2024 Apr; 36(15):e2310306. PubMed ID: 38194699
[TBL] [Abstract][Full Text] [Related]
9. FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection.
Meng H; Liao Z; Ji Y; Wang D; Han Y; Huang C; Hu X; Chen J; Zhang H; Li Z; Wang C; Sun H; Sun J; Chen L; Yin J; Zhao J; Xu T; Liu H
Signal Transduct Target Ther; 2024 Apr; 9(1):104. PubMed ID: 38654010
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
Qu B; Miskey C; Gömer A; Kleinert RDV; Ibanez SC; Eberle R; Ebenig A; Postmus D; Nocke MK; Herrmann M; Itotia TK; Herrmann ST; Heinen N; Höck S; Hastert FD; von Rhein C; Schürmann C; Li X; van Zandbergen G; Widera M; Ciesek S; Schnierle BS; Tarr AW; Steinmann E; Goffinet C; Pfaender S; Locker JK; Mühlebach MD; Todt D; Brown RJP
Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2407437121. PubMed ID: 38814864
[TBL] [Abstract][Full Text] [Related]
11. Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2.
Cai Z; Bai H; Ren D; Xue B; Liu Y; Gong T; Zhang X; Zhang P; Zhu J; Shi B; Zhang C
Virus Res; 2024 Jan; 339():199251. PubMed ID: 37884208
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression.
Paužuolis M; Fatykhova D; Zühlke B; Schwecke T; Neyazi M; Samperio-Ventayol P; Aguilar C; Schlegel N; Dökel S; Ralser M; Hocke A; Krempl C; Bartfeld S
Stem Cell Reports; 2024 May; 19(5):629-638. PubMed ID: 38670110
[TBL] [Abstract][Full Text] [Related]
13. Toll like receptor 4 mediates the inhibitory effect of SARS-CoV-2 spike protein on proximal tubule albumin endocytosis.
Silva-Aguiar RP; Teixeira DE; Peruchetti DB; Peres RAS; Alves SAS; Calil PT; Arruda LB; Costa LJ; Silva PL; Schmaier AH; Rocco PRM; Pinheiro AAS; Caruso-Neves C
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167155. PubMed ID: 38579939
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids.
Rahmani W; Chung H; Sinha S; Bui-Marinos MP; Arora R; Jaffer A; Corcoran JA; Biernaskie J; Chun J
iScience; 2022 Feb; 25(2):103818. PubMed ID: 35106453
[TBL] [Abstract][Full Text] [Related]
15. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
Gandikota C; Vaddadi K; Sivasami P; Huang C; Liang Y; Pushparaj S; Deng X; Channappanava R; Metcalf JP; Liu L
J Med Virol; 2024 Apr; 96(4):e29579. PubMed ID: 38572923
[TBL] [Abstract][Full Text] [Related]
16. Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.
Jeong GU; Hwang I; Lee W; Choi JH; Yoon GY; Kim HS; Yang JS; Kim KC; Lee JY; Kim SJ; Kwon YC; Kim KD
Exp Mol Med; 2024 May; 56(5):1221-1229. PubMed ID: 38816566
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
18. LRRC15 inhibits SARS-CoV-2 cellular entry in trans.
Song J; Chow RD; Peña-Hernández MA; Zhang L; Loeb SA; So EY; Liang OD; Ren P; Chen S; Wilen CB; Lee S
PLoS Biol; 2022 Oct; 20(10):e3001805. PubMed ID: 36228039
[TBL] [Abstract][Full Text] [Related]
19. Cellugyrin (synaptogyrin-2) dependent pathways are used by bacterial cytolethal distending toxin and SARS-CoV-2 virus to gain cell entry.
Boesze-Battaglia K; Cohen GH; Bates PF; Walker LM; Zekavat A; Shenker BJ
Front Cell Infect Microbiol; 2024; 14():1334224. PubMed ID: 38698905
[No Abstract] [Full Text] [Related]
20. Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.
Qiao Y; Wotring JW; Zhang CJ; Jiang X; Xiao L; Watt A; Gattis D; Scandalis E; Freier S; Zheng Y; Pretto CD; Ellison SJ; Swayze EE; Guo S; Sexton JZ; Chinnaiyan AM
PLoS One; 2023; 18(2):e0281281. PubMed ID: 36735698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
